Ozempic, Wegovy and Mounjaro have been all over the news as new, ‘miracle’ weight-loss drugs. But what’s the real story? And more importantly, what do heart patients need to know about them?

Join us Wednesday, March 13 as Dr. Disha Narang, an endocrinologist who specializes in obesity medicine, and culinary medicine with Endeavor Health (formerly NorthShore) tells us everything we need to know about these drugs and their possible impact on heart patients.

Dr. Narang joined Endeavor approximately three months ago as its new director of obesity medicine.

The meeting will take place Wednesday (a change from our usual Tuesday), March 13 at Evanston Hospital beginning at 6:30 p.m. Simply follow the signs from the lobby to our meeting room.

We also will be streaming the meeting for those who cannot attend. To join, use this link:

https://zoom.us/j/99887167977?pwd=dEJENmRFc2k5aHlvbjZlVnZiS0MrZz09

Posted in

Leave a comment